Fig. 6From: Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm studyAverage plasma concentration-time curve comparison after single and multiple dosesBack to article page